• pSivida Corp., of Watertown, Mass., said Iluvien (fluocinolone acetonide intravitreal implant) was launched in Germany in chronic diabetic macular edema by licensee Alimera Sciences Inc., of Atlanta. Earlier this month, Alimera resubmitted the new drug application for Iluvien, which has a PDUFA date of Oct. 17.